Mioduchoski, FNP-BC Medical Weight Loss, Wellness & Peptide Therapy Last Updated: July 2026 Information is reviewed regularly to reflect current insurance policies, Medicare guidance, physician-reviewed treatment recommendations, and clinical best practices
In TRIUMPH-4, it affected 8.8% of the 9mg group and 20.9% of the 12mg group, compared to just 0.7% on placebo
Associated with elevated NAD+ levels and SIRT1 activation in preclinical studies [2] [3]
24MechanickJI, YoudimA, JonesDB,
Timothy Brick, associate professor in Penn States College of Health and Human Development, and Jennifer Nyland, assistant professor in the department of neural and behavioral sciences at Penn State College of Medicine, will join the team as principal investigators
Additionally, retatrutide significantly improved blood lipids and blood pressure compared to placebo